Cargando…
Use of oral anticoagulants in African-American and Caucasian patients with atrial fibrillation: is there a treatment disparity?
Atrial fibrillation (AF) is a very common cardiac arrhythmia, and its prevalence is increasing along with aging in the developed world. This review discusses racial differences in the epidemiology and treatment of AF between African-American and Caucasian patients. Additionally, the effect of race o...
Autor principal: | Akinboboye, Olakunle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445875/ https://www.ncbi.nlm.nih.gov/pubmed/26056467 http://dx.doi.org/10.2147/JMDH.S74529 |
Ejemplares similares
-
Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022) -
Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease
por: Stoica, Mihai Ciprian, et al.
Publicado: (2021) -
The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013) -
Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients
por: Kazandjian, Dickran, et al.
Publicado: (2019) -
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)